Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Liver Transplantation

Free Subscription Articles published in PLoS One Retrieve available abstracts of 27 articles: HTML format

Single Articles

January 2026
1. MILISAVLJEVIC J, Stosic M, Jovanovic N, Adzic Vukicevic T, et al
   Latent TB infection in solid organ transplant recipients in Serbia: A single center experience from a low TB burden country.
   PLoS One. 2026;21:e0339925.
   PubMed     Abstract available
   
   
   
2. WAKIYA T, Sanada Y, Okada N, Hirata Y, et al
   Data-driven predictive modeling for massive intraoperative blood loss during living donor liver transplantation: Integrating machine learning techniques.
   PLoS One. 2026;21:e0326000.
   PubMed     Abstract available
   
   
   
3. WANG G, Liu L, Zhang H, Mao P, et al
   Effects of tacrolimus treatment on the gut microbiota and metabolites in liver transplant recipients.
   PLoS One. 2026;21:e0343817.
   PubMed     Abstract available
   
   
   January 2025
4. SHOURABIZADEH H, Aleman DM, Rousseau LM, Zheng K, et al
   Classification-augmented survival estimation (CASE): A novel method for individualized long-term survival prediction with application to liver transplantation.
   PLoS One. 2025;20:e0315928.
   PubMed     Abstract available
   
   
   
5. OHIRA M, Imaoka Y, Sato K, Imaoka K, et al
   A phase I/II study of adoptive immunotherapy using donor liver graft-derived NK cell-enriched immune cells to prevent severe infection after liver transplantation.
   PLoS One. 2025;20:e0313102.
   PubMed     Abstract available
   
   
   
6. MIYAGAWA-HAYASHINO A, Imura T, Takezawa T, Hirai M, et al
   Activation of S1PR2 on macrophages and the hepatocyte S1PR2/RhoA/ROCK1/MLC2 pathway in vanishing bile duct syndrome.
   PLoS One. 2025;20:e0317568.
   PubMed     Abstract available
   
   
   
7. CHEN K, Yang M, Li G, Wang W, et al
   Liver transplantation for NASH-related hepatocellular carcinoma versus non-NASH etiologies of hepatocellular carcinoma: A systematic review and meta-analysis.
   PLoS One. 2025;20:e0317730.
   PubMed     Abstract available
   
   
   
8. DALMAU M, Charco R, Bilbao I, Dopazo C, et al
   Heparinase I treatment to overcome RNA quantification interference in heparinized liver donor samples: One size fits all?
   PLoS One. 2025;20:e0322899.
   PubMed     Abstract available
   
   
   
9. SLIFIRSKI H, Raykateeraroj N, Armellini A, Hazard R, et al
   Ultra-massive fluid transfusion in adult liver transplant recipients: A single center observational study.
   PLoS One. 2025;20:e0325829.
   PubMed     Abstract available
   
   
   
10. LIU L, Wang Q, Qin S, Su C, et al
    Comprehensive characterization of the competitive endogenous RNA network revealing its immune-related functions in hepatic ischemia-reperfusion injury.
    PLoS One. 2025;20:e0327101.
    PubMed     Abstract available
    
    
    
11. AL-HUSSAINI A, AlMannai M, Alruwaithi M, Faqeih E, et al
    Clinical and molecular characterization of hepatic glycogen storage disease in Saudi Arabia.
    PLoS One. 2025;20:e0329008.
    PubMed     Abstract available
    
    
    
12. SCHREINER AD, Zhang J, Gebregziabher M, Marsden J, et al
    The association of race with time to severe liver disease diagnoses.
    PLoS One. 2025;20:e0334016.
    PubMed     Abstract available
    
    
    
13. ALQAHTANI SA, AlMuhaidib S, Raptis DA, Al-Hamoudi WK, et al
    Metabolic dysfunction-associated steatohepatitis is the leading indication for adult liver transplantation in Saudi Arabia.
    PLoS One. 2025;20:e0338438.
    PubMed     Abstract available
    
    
    
14. LOPEZ-DIAZ G, Sanchez-Lorencio MI, Inarrairaegui M, Gonzalez-Dieguez ML, et al
    Longitudinal biomarker progression and validation for predicting operational tolerance in a prospective multicenter liver transplantation immunosuppression withdrawal trial.
    PLoS One. 2025;20:e0326442.
    PubMed     Abstract available
    
    
    January 2024
15. GITTUS M, Moore J, Ong ACM
    Liver transplant recipients with polycystic liver disease have longer waiting times but better long-term clinical outcomes than those with liver disease due to other causes: A retrospective cross-sectional study.
    PLoS One. 2024;19:e0294717.
    PubMed     Abstract available
    
    
    
16. LAUE T, Junge N, Leiskau C, Mutschler F, et al
    Diminished measles immunity after paediatric liver transplantation-A retrospective, single-centre, cross-sectional analysis.
    PLoS One. 2024;19:e0296653.
    PubMed     Abstract available
    
    
    
17. LIU W, Jiang D, Schulz M, Figueiredo C, et al
    Machine perfusion of the liver and in vivo animal models: A systematic review of the preclinical research landscape.
    PLoS One. 2024;19:e0297942.
    PubMed     Abstract available
    
    
    
18. AZAMAR-LLAMAS D, Arenas-Martinez JS, Olivas-Martinez A, Jimenez JV, et al
    Impact of COVID-19 vaccination on liver transplant recipients. Experience in a reference center in Mexico.
    PLoS One. 2024;19:e0301198.
    PubMed     Abstract available
    
    
    
19. WILSON EA, Woodbury A, Williams KM, Coopersmith CM, et al
    OXIDATIVE study: A pilot prospective observational cohort study protocol examining the influence of peri-reperfusion hyperoxemia and immune dysregulation on early allograft dysfunction after orthotopic liver transplantation.
    PLoS One. 2024;19:e0301281.
    PubMed     Abstract available
    
    
    
20. YUAN C, Li W, Liu J, Li J, et al
    Frailty and transplant-free survival of patients with liver cirrhosis: A meta-analysis.
    PLoS One. 2024;19:e0302836.
    PubMed     Abstract available
    
    
    
21. WEINBERG L, Caragata R, Hazard R, Ludski J, et al
    Venovenous bypass in adult liver transplant recipients: A single-center observational case series.
    PLoS One. 2024;19:e0303631.
    PubMed     Abstract available
    
    
    
22. WOLPERT BM, Rothgerber DJ, Rosner AK, Brunier M, et al
    Evaluation of dynamic cerebrovascular autoregulation during liver transplantation.
    PLoS One. 2024;19:e0305658.
    PubMed     Abstract available
    
    
    January 2023
23. LE FLOC'H B, Costet N, Vu N, Bernabeu-Gentey P, et al
    Involvement of circulating soluble HLA-G after liver transplantation in the low immunogenicity of hepatic allograft.
    PLoS One. 2023;18:e0282736.
    PubMed     Abstract available
    
    
    
24. CHO Y, Lee JE, Jeong H, Kwon JH, et al
    Cumulative postoperative change in serum albumin levels and organ failure after living-donor liver transplantation: A retrospective cohort analysis.
    PLoS One. 2023;18:e0285734.
    PubMed     Abstract available
    
    
    
25. FITZPATRICK E, Filippi C, Jagadisan B, Shivapatham D, et al
    Intraperitoneal transplant of Hepatocytes co-Encapsulated with mesenchymal stromal cells in modified alginate microbeads for the treatment of acute Liver failure in Pediatric patients (HELP)-An open-label, single-arm Simon's two stage phase 1 study pr
    PLoS One. 2023;18:e0288185.
    PubMed     Abstract available
    
    
    
26. KITAHARA J, Yoshinaga T, Kakihara S, Hirano T, et al
    Ocular findings in patients with acquired ATTRv amyloidosis following domino liver transplantation.
    PLoS One. 2023;18:e0291716.
    PubMed     Abstract available
    
    
    
27. MOON JJ, Hong SK, Kim YC, Hong SY, et al
    Soluble suppression of tumorigenicity 2 is a potential predictor of post-liver transplant renal outcomes.
    PLoS One. 2023;18:e0293844.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Transplantation is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum